Study reveals common off-label dosing of direct oral anticoagulants

FHS
July 31, 2024
6:12 pm

Millions of Americans take anticoagulants, commonly known as blood thinners. These medications work to prevent blood clots that cause heart attack and stroke.

Valneva raises about €61M; Immuneering details new Phase 2a data

Plus, news about ONL Therapeutics, Cidara Therapeutics, Emergent BioSolutions, Vico Therapeutics and Centessa: Valneva gets €61.2M private placement: Valneva said the Sign up to read

September 14, 2024

Medtech can cope with GLP-1s but ‘fear and doubt’ suppressing stocks: analysts

Dive Brief: Fear and doubt created by the emergence of new obesity and diabetes drugs may affect medtech stocks for years, according to analysts at

October 17, 2023

Women on the Pill Have Comforting CVD Outcomes Years Down the Line

Reassuringly, a history of oral contraceptive use had no deleterious effects on cardiovascular disease (CVD) and survival over long-term follow-up, a U.K. Biobank study showed.

August 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.